Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Benefit plan design and prescription drug utilization among asthmatics: do patient copayments matter?

Crown WH, Berndt ER, Baser O, Finkelstein SN, Witt WP, Maguire J, Haver KE.

Front Health Policy Res. 2004;7:95-127.

PMID:
15612337
2.

Increasing pharmaceutical copayments: impact on asthma medication utilization and outcomes.

Campbell JD, Allen-Ramey F, Sajjan SG, Maiese EM, Sullivan SD.

Am J Manag Care. 2011 Oct;17(10):703-10.

PMID:
22106463
4.

The relationship of antidepressant prescribing concentration to treatment duration and cost.

Hodgkin D, Merrick EL, Hiatt D.

J Ment Health Policy Econ. 2012 Mar;15(1):3-11.

5.
6.

Ratio of controller to total asthma medications: determinants of the measure.

Broder MS, Gutierrez B, Chang E, Meddis D, Schatz M.

Am J Manag Care. 2010 Mar;16(3):170-8.

7.
8.

Impact of multitiered copayments on the use and cost of prescription drugs among Medicare beneficiaries.

Gilman BH, Kautter J.

Health Serv Res. 2008 Apr;43(2):478-95. doi: 10.1111/j.1475-6773.2007.00774.x.

9.
10.

The effect of a three-tier formulary on antidepressant utilization and expenditures.

Hodgkin D, Parks Thomas C, Simoni-Wastila L, Ritter GA, Lee S.

J Ment Health Policy Econ. 2008 Jun;11(2):67-77.

PMID:
18509214
11.

Effects of an increase in prescription copayment on utilization of low-sedating antihistamines and nasal steroids.

Meissner BL, Moore WM, Shinogle JA, Reeder CE, Little JM.

J Manag Care Pharm. 2004 May-Jun;10(3):226-33.

12.
13.

Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance.

Klepser DG, Huether JR, Handke LJ, Williams CE.

J Manag Care Pharm. 2007 Nov-Dec;13(9):765-77.

14.

Practice-level effects of interventions to improve asthma care in primary care settings: the Pediatric Asthma Care Patient Outcomes Research Team.

Finkelstein JA, Lozano P, Fuhlbrigge AL, Carey VJ, Inui TS, Soumerai SB, Sullivan SD, Wagner EH, Weiss ST, Weiss KB; Pediatric Asthma Care Patient Outcomes Research Team.

Health Serv Res. 2005 Dec;40(6 Pt 1):1737-57.

15.

The effect of pharmacy benefit design on patient-physician communication about costs.

Shrank WH, Fox SA, Kirk A, Ettner SL, Cantrell CH, Glassman P, Asch SM.

J Gen Intern Med. 2006 Apr;21(4):334-9.

16.

Disparities in asthma medication dispensing patterns: the case of pediatric asthma in Puerto Rico.

Vila D, Rand CS, Cabana MD, Quiñones A, Otero M, Gamache C, Ramírez R, García P, Canino G.

J Asthma. 2010 Dec;47(10):1136-41. doi: 10.3109/02770903.2010.517338. Epub 2010 Nov 1.

17.

Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy.

Goldman DP, Joyce GF, Karaca-Mandic P.

Am J Manag Care. 2006 Jan;12(1):21-8.

18.
19.
20.

Employer drug benefit plans and spending on prescription drugs.

Joyce GF, Escarce JJ, Solomon MD, Goldman DP.

JAMA. 2002 Oct 9;288(14):1733-9. Erratum in: JAMA 2002 Nov 20;288(19):2409.

PMID:
12365957

Supplemental Content

Support Center